EGFR and cancer: AuNPs are easily functionalized, stable, low toxic, biocompatible, possess a large surface area for drug attachment, and enable fluorescence and photoacoustic chromatography imaging, controlled drug release, and photothermal therapy. EGFR inhibitors and tumor-targeting peptides can target cancer cells and block signaling pathway